[Combined administration of metoclopramide, scopolan and proacid in the treatment of chronic duodenal ulcer].
D000328:Adult; D000535:Aluminum; D000536:Aluminum Hydroxide; D002086:Butylscopolammonium Bromide / Q000008:administration & dosage* / Q000627:therapeutic use; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005260:Female; D005998:Glycine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D012602:Scopolamine Derivatives / Q000008:administration & dosage*
D012602:Scopolamine Derivatives; D002086:Butylscopolammonium Bromide; D000536:Aluminum Hydroxide; D000535:Aluminum; C007420:dihydroxyaluminum aminoacetate; D008787:Metoclopramide; D005998:Glycine
Skojarzone stosowanie metoklopramidu, skopolanu i proacydu w leczeniu choroby wrzodowej dwunastnicy.